Vericel (NASDAQ:VCEL) Receives Overweight Rating from Stephens
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […]
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […]
